Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stock Forecast

Stock Price Forecast

The 19 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $96.79, which forecasts a 23.93% increase in the stock price over the next year. The lowest target is $81 and the highest is $110.

Price Target: $96.79 (+23.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$81	$96.79	$98	$110
Change	+3.71%	+23.93%	+25.48%	+40.85%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	6	7	6	7	7
Buy	5	6	6	7	7	7
Hold	6	7	7	7	7	7
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	19	20	20	21	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Rick Wise Stifel	Stifel	Strong Buy Maintains $105 → $110	Strong Buy	Maintains	$105 → $110	+40.85%	Jan 20, 2026
Adam Maeder Piper Sandler	Piper Sandler	Buy Maintains $95 → $98	Buy	Maintains	$95 → $98	+25.48%	Jan 20, 2026
Danielle Antalffy UBS	UBS	Hold Maintains $92 → $95	Hold	Maintains	$92 → $95	+21.64%	Jan 12, 2026
Matt Miksic Barclays	Barclays	Buy Maintains $103 → $104	Buy	Maintains	$103 → $104	+33.16%	Jan 12, 2026
Joshua Jennings TD Cowen	TD Cowen	Hold → Strong Buy Upgrades $90 → $97	Hold → Strong Buy	Upgrades	$90 → $97	+24.20%	Jan 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.22B

Increased by 14.29%

from 5.44B

Revenue Next Year

6.82B

Increased by 9.73%

from 6.22B

EPS This Year

2.65

Decreased by -61.92%

from 6.97

EPS Next Year

2.96

Increased by 11.57%

from 2.65

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.39B	5.23B	4.46B	5.01B	5.44B	6.22B	6.82B
Revenue Growth	0.88%	19.29%	-14.69%	12.23%	8.57%	14.29%	9.73%
EPS	1.30	2.38	2.44	2.30	6.97	2.65	2.96
EPS Growth	-20.73%	83.08%	2.40%	-5.44%	202.39%	-61.92%	11.57%
Forward PE	-	-	-	-	-	29.44	26.38
No. Analysts	-	-	-	-	-	39	38

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	6.4B	7.1B
Avg	6.2B	6.8B
Low	5.8B	6.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	17.7%	14.3%
Avg	14.3%	9.7%
Low	6.2%	0.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	2.76	3.28
Avg	2.65	2.96
Low	2.09	2.33

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-60.4%	23.5%
Avg	-61.9%	11.6%
Low	-70.0%	-12.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.